tiprankstipranks
LSL Pharma Group Inc (TSE:LSL)
TSXV:LSL
Canadian Market
Holding TSE:LSL?
Track your performance easily

LSL Pharma Group Inc (LSL) Income Statement

0 Followers

LSL Pharma Group Inc Income Statement

Last quarter (Q2 2024), LSL Pharma Group Inc's total revenue was C$4.19M, an increase of 106.05% from the same quarter last year. In Q2, LSL Pharma Group Inc's net income was C$-516.00K. See LSL Pharma Group Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Jul 22Dec 21Dec 20Sep 20
Total Revenue
C$ 14.32MC$ 10.03M-C$ 8.77MC$ 2.51MC$ 4.82M
Cost of Revenue
C$ 11.08MC$ 8.38M-C$ 6.25MC$ 1.57MC$ 4.32M
Gross Profit
C$ 3.25MC$ 1.65M-C$ 2.53MC$ 943.03KC$ 507.58K
Operating Expense
C$ 3.49MC$ 8.31MC$ 70.85KC$ 2.59MC$ 378.97KC$ -301.69K
Operating Income
C$ -237.68KC$ -6.67MC$ -70.85KC$ -65.27KC$ 564.05KC$ 809.27K
Net Non Operating Interest Income Expense
C$ -1.61MC$ -1.57MC$ -3.37KC$ -1.71MC$ -358.25KC$ -726.64K
Other Income Expense
C$ 186.26KC$ 236.00K-C$ 141.32K--
Pretax Income
C$ -2.03MC$ -8.47MC$ -74.22KC$ -1.63MC$ 205.80KC$ 82.63K
Tax Provision
---C$ 147.46KC$ 53.34KC$ -5.38K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -2.03MC$ -8.47MC$ -74.22KC$ -1.78MC$ 152.47KC$ 88.01K
Basic EPS
C$ 8.79C$ -0.11-C$ -0.01C$ <0.01C$ <0.01
Diluted EPS
C$ 8.79C$ -0.11-C$ -0.01C$ <0.01C$ <0.01
Basic Average Shares
C$ 359.30MC$ 80.35M-C$ 131.37MC$ 131.37MC$ 131.37M
Diluted Average Shares
C$ 359.42MC$ 80.35M-C$ 131.37MC$ 131.37MC$ 131.37M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 805.21M-C$ 70.85KC$ 8.84MC$ 1.95MC$ 4.01M
Net Income From Continuing And Discontinued Operation
C$ -2.03MC$ -8.47MC$ -74.22KC$ -1.78MC$ 152.47KC$ 88.01K
Normalized Income
C$ -1.74MC$ -6.23MC$ -54.55KC$ -1.88MC$ 152.47KC$ 88.01K
Interest Expense
---C$ 1.59MC$ 314.80KC$ 534.96K
EBIT
C$ -423.94KC$ -6.90MC$ -70.85KC$ -42.44KC$ 520.60KC$ 617.59K
EBITDA
C$ 513.19KC$ -5.77MC$ -70.85KC$ 931.55KC$ 747.58KC$ 990.62K
Currency in CAD

LSL Pharma Group Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis